click here to return to homepage
 
 

Acceava®, BinaxNOW®, Clearview®, RUBELLA-plus® are registered trademarks of the Inverness Medical family of companies

More Information

Clearview Chlamydia

Clearview® Chlamydia is a rapid, easy-to-use test for the detection of Chlamydia trachomatis from female endocervical swab specimens.

Clearly different

Clearview® Chlamydia uses a patented, innovative technology to provide highly sensitive and specific results.

  • Fast: test provides positive results in just 15 minutes

  • Easy: assay can be easily performed and interpreted by all staff members

  • Reliable: highly sensitive assay with built-in control ensures accuracy

  • Flexible: test provides results while the patient waits

Clearly better

Diagnosis with Clearview® Chlamydia enables immediate and necessary treatment.

  • Treatment may eliminate the development of serious, potentially life-threatening health problems

  • Detection and proper treatment may prevent transmission to an unborn child as well as to sexual partners

 

Clearview® Chlamydia Test Procedure

Step 1

Fill extraction tube to the line with extraction buffer. Add sample swab.

 

 

 

 

 

Step 2Incubate tube for 10 minutes in the Clearview
Workstation.

 



 

 

Step 3

Remove swab and cap extraction tube. Add 5 drops of extract to the Sample Window.

 

 

 

 

Step 4Read results in 15 minutes.

 

 

 

 

A line in the result window (center) indicates a positive result. Clearview's control window (right) ensures that results can be interpreted with confidence.

For full instructions, see package insert.

About Chlamydia

Chlamydia is caused by the bacterium Chlamydia trachomatis and is the most frequently reported bacterial sexually transmitted disease in the U.S. An estimated 2.8 million Americans are infected each year.1

Chlamydia is often called a "silent" disease because it usually does not produce symptoms. If left untreated, chlamydia can lead to serious health problems in women, including pelvic inflammatory disease (PID). PID can cause permanent damage to a woman's reproductive organs, which can lead to chronic pelvic pain, infertility, and potentially fatal ectopic pregnancy.1 Chlamydia can be passed from a pregnant mother to her unborn child; in fact, chlamydia is a leading cause of early infant pneumonia and conjunctivitis in newborns.1

Annual screening for chlamydia is recommended for all sexually active women age 25 and younger and for older women with risk factors for chlamydia. All pregnant women should also be screened.1 Once detected, chlamydia can be treated and cured with antibiotics.

Reference

  1. Centers for Disease Control. Chlamydia Fact Sheet. Available at: http://www.cdc.gov/std/Chlamydia/STDFact-Chlamydia.htm. Accessed March 30, 2005.

 

Specifications 
Order No. 135301
Qty: 20 Tests
CPT*: 87810, 87320
CLIA: Non-waived
Contact: (800) 257-9525

Accessories: 135315: Female Collection Kit
130035: Workstation

 Clearview Chlamydia
Useful Downloads
Product Brochure
Reimbursement
Look up CPT & ICD-9 codes, coverage policies, and state by state Medicare reimbursement information at: www.codemap.com/
inverness
 or call the CodeMap Hotline: 847.381.5465 x5, or email: customerservice@
codemap.com


*It is always the provider's responsibility to establish appropriate coding & charges
For technical information including: CLSI procedures, Material Safety Data Sheets (MSDS) and package inserts,
call Technical Services at 800-257-9525





Please note that individual products may have different specifications in various markets. Also, some products may not be available in all markets worldwide. The products on this website are available in the United States of America.